{"id":104,"date":"2021-05-03T21:14:58","date_gmt":"2021-05-03T21:14:58","guid":{"rendered":"https:\/\/preview.wepoge.com\/?p=104"},"modified":"2022-04-25T08:50:54","modified_gmt":"2022-04-25T08:50:54","slug":"theraxen-sa","status":"publish","type":"post","link":"https:\/\/www.newmrna.eu\/?p=104","title":{"rendered":"Theraxen SA"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Principle investigator: <strong>Dr. Philippe Marli\u00e8re<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Domain of expertise: <strong>Synthetic Biology approaches for drug development<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The metabolic engineering expertise required for redesigning RNA synthesis will be provided in the lab of Prof. V\u00e9ronique de Berardinis by PI Dr. Val\u00e9rie Pez\u00f3 (CEA) together with Dr. Philippe Marli\u00e8re (TXN). Together, they have a stellar track record in the field of introducing xenometabolism into model bacteria. The practical work will be mainly done at CEA, where Dr. Pez\u00f3 entertains a state-of-the-art lab in bacterial engineering, and the computational work at TXN.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Principle investigator: Dr. Philippe Marli\u00e8re Domain of expertise: Synthetic Biology approaches for drug development The metabolic engineering expertise required for redesigning RNA synthesis will be [&#8230;]<\/p>\n","protected":false},"author":1,"featured_media":108,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-104","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-consortium"],"_links":{"self":[{"href":"https:\/\/www.newmrna.eu\/index.php?rest_route=\/wp\/v2\/posts\/104","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newmrna.eu\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newmrna.eu\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newmrna.eu\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newmrna.eu\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=104"}],"version-history":[{"count":3,"href":"https:\/\/www.newmrna.eu\/index.php?rest_route=\/wp\/v2\/posts\/104\/revisions"}],"predecessor-version":[{"id":293,"href":"https:\/\/www.newmrna.eu\/index.php?rest_route=\/wp\/v2\/posts\/104\/revisions\/293"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newmrna.eu\/index.php?rest_route=\/wp\/v2\/media\/108"}],"wp:attachment":[{"href":"https:\/\/www.newmrna.eu\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=104"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newmrna.eu\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=104"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newmrna.eu\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=104"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}